<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01757678</url>
  </required_header>
  <id_info>
    <org_study_id>CP-902-001</org_study_id>
    <nct_id>NCT01757678</nct_id>
  </id_info>
  <brief_title>HeartFlowNXT - HeartFlow Analysis of Coronary Blood Flow Using Coronary CT Angiography</brief_title>
  <acronym>HFNXT</acronym>
  <official_title>HeartFlowNXT - HeartFlow Analysis of Coronary Blood Flow Using Coronary CT Angiography: NeXt sTeps</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HeartFlow, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Case Western Reserve University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>HeartFlow, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the diagnostic performance of FFRCT by coronary computed tomographic angiography
      (cCTA), as compared to cCTA alone, for non-invasive determination of the presence of a
      hemodynamically significant coronary lesion, using direct measurement of fractional flow
      reserve (FFR) during cardiac catheterization as a reference standard.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recently, coronary Computed Tomography Angiography (cCTA) of 64-detector rows or greater has
      emerged as a novel non-invasive imaging modality that is capable of providing high-resolution
      images of coronary artery lesions (Budoff 2008; Miller 2008; Meijboom 2008). While cCTA
      demonstrates good diagnostic performance for detection and exclusion of anatomic coronary
      artery stenoses, numerous prior studies have revealed an unreliable relationship between
      detection of obstructive anatomic coronary artery stenoses by cCTA and hemodynamically
      (HD)-significant coronary artery disease (CAD), identified by myocardial perfusion SPECT or
      fractional flow reserve (FFR) (Di Carli 2007; Klauss 2007; Rispler 2007; van Werkhoven 2009).
      Individual subjects may have HD-significant CAD despite cCTA assessment demonstrating
      angiographically mild (&lt;50%) maximal stenosis (Schuijf 2006). These findings emphasize the
      need for additional measures beyond anatomic stenosis severity for the detection and
      exclusion of HD-significant CAD.

      Measurement of FFR during invasive cardiac catheterization represents the &quot;gold standard&quot; for
      assessment of the hemodynamic significance of coronary artery lesions (Kern 2010). Anatomic
      coronary artery stenosis assessment by quantitative coronary angiography (QCA) also
      correlates very poorly with FFR Melikian 2010). This was highlighted by the results of the
      FAME study in which FFR-guided coronary revascularization improved healthcare and economic
      outcomes compared to the conventional angiographically guided strategy (Pijls 2010; Tonino
      2009; Tonino 2010).

      The major disadvantage of FFR is that it has to be measured invasively. HeartFlow, Inc.
      ('HeartFlow') has recently developed a non-invasive method to determine FFR which computes
      the hemodynamic significance of CAD (FFRCT) from subject-specific cCTA data using
      computational fluid dynamics under rest and simulated maximal coronary hyperemic conditions.
      Preliminary results in subjects suggest that FFRCT accurately predicts the hemodynamic
      significance of coronary lesions when compared to directly-measured FFR during invasive
      cardiac catheterization (Koo 2011).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>prospective, multicenter study to evaluate the diagnostic performance of cCTA plus FFRCT employing ≥64-detector row CT scanners for the detection and exclusion of significant obstructive CAD, as defined by invasively-measured FFR, the reference standard</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double</masking>
    <masking_description>No Masking</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>AUC of FFRct Versus Coronary CTA for Demonstration of Ischemia (≤0.80) on a Per-patient Basis</measure>
    <time_frame>1 day; Outcome measures were comparing FFRct to FFR. Incident time for FFR was dependent on the length of time on the cath procedure. FFRct was done remotely at HeartFlow's processing center in Redwood City with a turnaround time of 24 hours from CT scan.</time_frame>
    <description>The primary statistical measure will be the area under the receiver operating characteristic curve (AUC of ROC) of a patient-based model to detect hemodynamically significant obstruction. ROC graphs the change in sensitivity as the cut-point for positive/negative diagnosis moves from its lower to upper limit. FFR is used as the reference standard to determine the presence or absence of hemodynamic obstruction. For FFR, hemodynamically-significant obstruction of a coronary artery is defined as an FFR≤0.80 in any major epicardial coronary artery segment with diameter ≥2.0 mm during adenosine-mediated hyperemia. For cCTA, hemodynamically-significant obstruction of a coronary artery is defined as a stenosis &gt;50% . FFRCT will be calculated for each patient as the minimum FFRCT in any coronary artery segment . cCTA stenosis will be calculated for each patient as the highest cCTA stenosis category for any vessel all measurements will take place only in segments with diameter ≥2.0 mm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>AUC of FFRct Versus Coronary CTA for Demonstration of Ischemia (≤0.80) on a Per-vessel Basis</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Per-Patient Analysis: Diagnostic Performance of FFRct, Coronary CTA, and ICA</measure>
    <time_frame>1 day; Outcome measures were comparing FFRct to FFR. Incident time for FFR was dependent on the length of time on the cath procedure. FFRct was done remotely at HeartFlow's processing center in Redwood City with a turnaround time of 24 hours from CT scan.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Per Vessel Diagnostic Performance of FFRct, Coronary CTA, and ICA</measure>
    <time_frame>1 day; Outcome measures were comparing FFRct to FFR. Incident time for FFR was dependent on the length of time on the cath procedure. FFRct was done remotely at HeartFlow's processing center in Redwood City with a turnaround time of 24 hours from CT scan.</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">276</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Standard of care: FFR, ICA, cCTA, FFRct</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>(ICA) Invasive coronary angiography with (FFR) fractional flow reserve measurement in standard of care environment, and cCTA (computed coronary tomography angiography) and FFRct Analysis (fractional flow reserve computed tomography)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ICA (Invasive Coronary Angiography)</intervention_name>
    <description>Per the protocol, patients will have an Invasive Coronary Angiography.</description>
    <arm_group_label>Standard of care: FFR, ICA, cCTA, FFRct</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>FFR (Fractional Flow Reserve)</intervention_name>
    <description>Per the protocol, patients will have a Fractional Flow Reserve procedure.</description>
    <arm_group_label>Standard of care: FFR, ICA, cCTA, FFRct</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cCTA (coronary computed tomography angiography)</intervention_name>
    <description>Per the protocol, patients will have a coronary computed tomography angiography.</description>
    <arm_group_label>Standard of care: FFR, ICA, cCTA, FFRct</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>FFRct Analysis (Fractional Flow Reserve Computed Tomography)</intervention_name>
    <description>Per the protocol, patients will have a fractional flow reserve computed tomography.</description>
    <arm_group_label>Standard of care: FFR, ICA, cCTA, FFRct</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥18 years

          -  Subject providing written informed consent

          -  Scheduled to undergo a clinically indicated Invasive Coronary Angiogram (ICA)

          -  Has had ≥64 multidetector row cCTA within 60 days prior to ICA or agrees to undergo
             cCTA with ≥64 multidetector row cCTA within 60 days prior to ICA

        Exclusion Criteria:

          -  Percutaneous coronary intervention (PCI) has been performed any time prior to ICA.

          -  Prior coronary artery bypass graft (CABG) surgery

          -  Contraindication to beta blocker agents, nitrates, or adenosine, including 2nd or 3rd
             degree heart block; sick sinus syndrome; long QT syndrome; severe hypotension; severe
             asthma, severe COPD or bronchodilator-dependent COPD

          -  Suspicion of acute coronary syndrome (acute myocardial infarction and unstable angina)

          -  Recent prior myocardial infarction within 30 days prior to cCTA or between cCTA and
             ICA

          -  Known complex congenital heart disease

          -  Prior pacemaker or internal defibrillator lead implantation

          -  Prosthetic heart valve

          -  Tachycardia or significant arrhythmia

          -  Impaired chronic renal function (serum creatinine &gt;1.5 mg/dl)

          -  Subjects with known anaphylactic allergy to iodinated contrast

          -  Pregnancy or unknown pregnancy status in subject of childbearing potential

          -  Body mass index &gt;35 at time of cCTA

          -  Subject requires an emergent procedure

          -  Evidence of ongoing or active clinical instability, including acute chest pain (sudden
             onset), cardiogenic shock, unstable blood pressure with systolic blood pressure &lt;90
             mmHg, and severe congestive heart failure (NYHA III or IV) or acute pulmonary edema

          -  Any active, serious, life-threatening disease with a life expectancy of less than 2
             months

          -  Inability to comply with study procedures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bjarne Norgaard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Arhus</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 18, 2012</study_first_submitted>
  <study_first_submitted_qc>December 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2012</study_first_posted>
  <results_first_submitted>July 28, 2014</results_first_submitted>
  <results_first_submitted_qc>November 13, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">November 14, 2017</results_first_posted>
  <last_update_submitted>November 13, 2017</last_update_submitted>
  <last_update_submitted_qc>November 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronary Artery Disease Computed Fractional Flow Reserve</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard of Care: FFR and ICA</title>
          <description>Single arm
Measured FFR: Fractional Flow Reserve</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="276"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="276"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard of Care: FFR and ICA</title>
          <description>Single arm
Measured FFR (Fractional Flow Reserve) and ICA (Invasive Coronary Angiography)</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="276"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="101"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="175"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="91"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="179"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>With Diabetes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Without Diabetes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="214"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hypertension</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>With Hypertension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="188"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Without Hypertension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hyperlipidemia</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>With Hyperlipidemia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="214"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Without Hyperlipidemia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown Hiperlipidemia Status</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Current smoker</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Current Smoker</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Former Smoker</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Never Smoked</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="118"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous myocardial infarction</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Previous Myocardial Infarction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No Previous Myocardial Infarction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="271"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index, kg/m^2</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Creatinine, mg/dl</title>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.9" spread=".2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Left ventricular ejection fraction, %</title>
          <units>percent</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Secondary</type>
        <title>AUC of FFRct Versus Coronary CTA for Demonstration of Ischemia (≤0.80) on a Per-vessel Basis</title>
        <time_frame>1 day</time_frame>
        <population>22 of the 276 enrolled subjects were excluded by the FFR/QCA Core Lab, leaving an ITD population of 254 subjects. 3 additional subjects were excluded from the ITD analysis due to missing cCTA 30%-90% stenosis by coronary CTA.</population>
        <group_list>
          <group group_id="O1">
            <title>FFRct vs. FFR</title>
          </group>
          <group group_id="O2">
            <title>cCTA vs. FFR</title>
          </group>
        </group_list>
        <measure>
          <title>AUC of FFRct Versus Coronary CTA for Demonstration of Ischemia (≤0.80) on a Per-vessel Basis</title>
          <population>22 of the 276 enrolled subjects were excluded by the FFR/QCA Core Lab, leaving an ITD population of 254 subjects. 3 additional subjects were excluded from the ITD analysis due to missing cCTA 30%-90% stenosis by coronary CTA.</population>
          <units>probability</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>Vessels</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="251"/>
                <count group_id="O2" value="251"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Vessels</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="484"/>
                <count group_id="O2" value="484"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".93" lower_limit="0.91" upper_limit="0.95"/>
                    <measurement group_id="O2" value=".79" lower_limit=".74" upper_limit=".84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Difference in Probability</param_type>
            <param_value>.14</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.09</ci_lower_limit>
            <ci_upper_limit>.19</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>AUC of FFRct Versus Coronary CTA for Demonstration of Ischemia (≤0.80) on a Per-patient Basis</title>
        <description>The primary statistical measure will be the area under the receiver operating characteristic curve (AUC of ROC) of a patient-based model to detect hemodynamically significant obstruction. ROC graphs the change in sensitivity as the cut-point for positive/negative diagnosis moves from its lower to upper limit. FFR is used as the reference standard to determine the presence or absence of hemodynamic obstruction. For FFR, hemodynamically-significant obstruction of a coronary artery is defined as an FFR≤0.80 in any major epicardial coronary artery segment with diameter ≥2.0 mm during adenosine-mediated hyperemia. For cCTA, hemodynamically-significant obstruction of a coronary artery is defined as a stenosis &gt;50% . FFRCT will be calculated for each patient as the minimum FFRCT in any coronary artery segment . cCTA stenosis will be calculated for each patient as the highest cCTA stenosis category for any vessel all measurements will take place only in segments with diameter ≥2.0 mm.</description>
        <time_frame>1 day; Outcome measures were comparing FFRct to FFR. Incident time for FFR was dependent on the length of time on the cath procedure. FFRct was done remotely at HeartFlow's processing center in Redwood City with a turnaround time of 24 hours from CT scan.</time_frame>
        <population>22 of the 276 enrolled subjects were excluded by the FFR/QCA Core Lab, leaving an ITD population of 254 subjects. 3 additional subjects were excluded from the ITD analysis due to missing cCTA 30%-90% stenosis by coronary CTA.</population>
        <group_list>
          <group group_id="O1">
            <title>FFRct vs. FFR</title>
          </group>
          <group group_id="O2">
            <title>cCTA vs. FFR</title>
          </group>
        </group_list>
        <measure>
          <title>AUC of FFRct Versus Coronary CTA for Demonstration of Ischemia (≤0.80) on a Per-patient Basis</title>
          <description>The primary statistical measure will be the area under the receiver operating characteristic curve (AUC of ROC) of a patient-based model to detect hemodynamically significant obstruction. ROC graphs the change in sensitivity as the cut-point for positive/negative diagnosis moves from its lower to upper limit. FFR is used as the reference standard to determine the presence or absence of hemodynamic obstruction. For FFR, hemodynamically-significant obstruction of a coronary artery is defined as an FFR≤0.80 in any major epicardial coronary artery segment with diameter ≥2.0 mm during adenosine-mediated hyperemia. For cCTA, hemodynamically-significant obstruction of a coronary artery is defined as a stenosis &gt;50% . FFRCT will be calculated for each patient as the minimum FFRCT in any coronary artery segment . cCTA stenosis will be calculated for each patient as the highest cCTA stenosis category for any vessel all measurements will take place only in segments with diameter ≥2.0 mm.</description>
          <population>22 of the 276 enrolled subjects were excluded by the FFR/QCA Core Lab, leaving an ITD population of 254 subjects. 3 additional subjects were excluded from the ITD analysis due to missing cCTA 30%-90% stenosis by coronary CTA.</population>
          <units>probablility</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="251"/>
                <count group_id="O2" value="251"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".90" lower_limit=".87" upper_limit=".94"/>
                    <measurement group_id="O2" value=".81" lower_limit=".76" upper_limit=".87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Difference in Probability</param_type>
            <param_value>.09</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.04</ci_lower_limit>
            <ci_upper_limit>.14</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Per-Patient Analysis: Diagnostic Performance of FFRct, Coronary CTA, and ICA</title>
        <time_frame>1 day; Outcome measures were comparing FFRct to FFR. Incident time for FFR was dependent on the length of time on the cath procedure. FFRct was done remotely at HeartFlow's processing center in Redwood City with a turnaround time of 24 hours from CT scan.</time_frame>
        <population>22 of the 276 enrolled subjects were excluded from the analysis by the FFR/QCA Core Lab.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care: FFR and ICA</title>
            <description>(ICA) Invasive coronary angiography with (FFR) fractional flow reserve measurement in standard of care environment.</description>
          </group>
        </group_list>
        <measure>
          <title>Per-Patient Analysis: Diagnostic Performance of FFRct, Coronary CTA, and ICA</title>
          <population>22 of the 276 enrolled subjects were excluded from the analysis by the FFR/QCA Core Lab.</population>
          <units>percentage of tests</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="254"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Accuracy: ICA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77" lower_limit="71" upper_limit="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Accuracy: FFRct ≤ 0.80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81" lower_limit="76" upper_limit="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Accuracy: Coronary CTA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53" lower_limit="47" upper_limit="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sensitivity: ICA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64" lower_limit="53" upper_limit="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sensitivity: FFRct ≤ 0.80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86" lower_limit="77" upper_limit="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sensitivity: Coronary CTA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94" lower_limit="86" upper_limit="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specificity: ICA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83" lower_limit="77" upper_limit="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specificity: FFRct ≤ 0.80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79" lower_limit="72" upper_limit="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specificity: Coronary CTA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34" lower_limit="27" upper_limit="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Predictive Value: ICA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63" lower_limit="52" upper_limit="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Predictive Value: FFRct ≤ 0.80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65" lower_limit="56" upper_limit="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Predictive Value: cCTA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40" lower_limit="33" upper_limit="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Negative Predictive Value: ICA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83" lower_limit="77" upper_limit="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Negative Predictive Value: FFRct ≤ 0.80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93" lower_limit="87" upper_limit="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Negative Predictive Value: cCTA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92" lower_limit="83" upper_limit="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Per Vessel Diagnostic Performance of FFRct, Coronary CTA, and ICA</title>
        <time_frame>1 day; Outcome measures were comparing FFRct to FFR. Incident time for FFR was dependent on the length of time on the cath procedure. FFRct was done remotely at HeartFlow's processing center in Redwood City with a turnaround time of 24 hours from CT scan.</time_frame>
        <population>22 of the 276 enrolled subjects were excluded from the analysis by the FFR/QCA Core Lab.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care: FFR and ICA</title>
            <description>(ICA) Invasive coronary angiography with (FFR) fractional flow reserve measurement in standard of care environment.</description>
          </group>
        </group_list>
        <measure>
          <title>Per Vessel Diagnostic Performance of FFRct, Coronary CTA, and ICA</title>
          <population>22 of the 276 enrolled subjects were excluded from the analysis by the FFR/QCA Core Lab.</population>
          <units>percentage of tests</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>Vessels</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="254"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Vessels</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="484"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Accuracy: ICA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82" lower_limit="79" upper_limit="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Accuracy: FFRct ≤ 0.80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86" lower_limit="83" upper_limit="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Accuracy: Coronary CTA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65" lower_limit="61" upper_limit="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sensitivity: ICA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55" lower_limit="45" upper_limit="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sensitivity: FFRct ≤ 0.80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84" lower_limit="75" upper_limit="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sensitivity: Coronary CTA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83" lower_limit="74" upper_limit="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specificity: ICA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90" lower_limit="86" upper_limit="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specificity: FFRct ≤ 0.80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86" lower_limit="82" upper_limit="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specificity: Coronary CTA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60" lower_limit="56" upper_limit="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Predictive Value: ICA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58" lower_limit="48" upper_limit="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Predictive Value: FFRct ≤ 0.80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61" lower_limit="53" upper_limit="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Predictive Value: cCTA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33" lower_limit="27" upper_limit="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Negative Predictive Value: ICA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88" lower_limit="85" upper_limit="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Negative Predictive Value: FFRct ≤ 0.80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95" lower_limit="93" upper_limit="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Negative Predictive Value: cCTA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92" lower_limit="88" upper_limit="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Per-Patient Diagnostic Performance of FFRct in Patients With Intermediate Stenosis Severity (30%-70%) According to Coronary CTA</title>
        <time_frame>1 day; Outcome measures were comparing FFRct to FFR. Incident time for FFR was dependent on the length of time on the cath procedure. FFRct was done remotely at HeartFlow's processing center in Redwood City with a turnaround time of 24 hours from CT scan.</time_frame>
        <population>Patients with intermediate stenosis severity (30%-70%) according to coronary CTA.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care: FFR and ICA</title>
            <description>(ICA) Invasive coronary angiography with (FFR) fractional flow reserve measurement in standard of care environment.</description>
          </group>
        </group_list>
        <measure>
          <title>Per-Patient Diagnostic Performance of FFRct in Patients With Intermediate Stenosis Severity (30%-70%) According to Coronary CTA</title>
          <population>Patients with intermediate stenosis severity (30%-70%) according to coronary CTA.</population>
          <units>percentage of tests</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="235"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Accuracy: FFRct ≤ 0.80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80" lower_limit="75" upper_limit="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Accuracy: Coronary CTA Stenosis &gt; 50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51" lower_limit="44" upper_limit="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sensitivity: FFRct ≤ 0.80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85" lower_limit="74" upper_limit="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sensitivity: Coronary CTA Stenosis &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93" lower_limit="85" upper_limit="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specificity: FFRct ≤ 0.80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79" lower_limit="72" upper_limit="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Specificity: Coronary CTA Stenosis &gt; 50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32" lower_limit="26" upper_limit="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Predictive Value: FFRct ≤ 0.80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63" lower_limit="53" upper_limit="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive Predictive Value: cCTA Stenosis &gt; 50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37" lower_limit="31" upper_limit="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Negative Predictive Value: FFRct ≤ 0.80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92" lower_limit="87" upper_limit="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Negative Predictive Value: cCTA Stenosis &gt; 50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91" lower_limit="81" upper_limit="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Index Procedure through hospital discharge</time_frame>
      <desc>Note: this study involved prospective data collection to validate in a blinded manner a non-invasive test therefore adverse event information is reported based only on the standard of care index procedure.</desc>
      <group_list>
        <group group_id="E1">
          <title>Standard of Care: ICA (Invasive Coronary Angiography)</title>
          <description>(ICA) Invasive coronary angiography in standard of care environment.</description>
        </group>
        <group group_id="E2">
          <title>Standard of Care: cCTA (Coronary Computed Tomography Angio)</title>
          <description>(cCTA) Coronary computed tomography angiography in standard of care environment.</description>
        </group>
        <group group_id="E3">
          <title>Standard of Care: FFR (Fractional Flow Reserve)</title>
          <description>(FFR) Fractional flow reserve in standard of care environment.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="276"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="276"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="276"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Fever</sub_title>
                <description>Fever with prolonged hospitalization</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Coronary Dissection during invasive FFR measurement requiring percutaneous coronary intervention</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Transient cerebral ischemic attacks after ICA and invasive FFR measurement</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="276"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="276"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Angina Pectoris</sub_title>
                <description>Angina pectoris following catheterization</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="53" subjects_at_risk="276"/>
                <counts group_id="E2" subjects_affected="53" subjects_at_risk="276"/>
                <counts group_id="E3" subjects_affected="53" subjects_at_risk="276"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Procedural Hypotension</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="276"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="276"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Procedural Arrhythmia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="276"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="276"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Procedural Allergic Reaction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="276"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="276"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Procedural Angina/Chest Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="276"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="276"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Procedural TIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="276"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="276"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Procedural Vasovagal Response</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="276"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="276"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Procedural Blurred Vision</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Procedural Complete Heart Block</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Procedural Coughing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Procedural Dissection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Procedural Distal Embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Procedural Dyspnea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Procedural Headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Procedural Numbness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Procedural Perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Procedural Rash/Urticaria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Procedural sickness during and after Adenosine</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Procedural Vomiting</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Discharge Hematoma</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="276"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="276"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Discharge Angina/Chest Pain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="276"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="276"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Discharge Headache</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="276"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="276"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Discharge Arrhythmia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="276"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="276"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Discharge Absence Seizure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Discharge Blurred Vision</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Discharge Chest Tightness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Discharge Facial and Chest Rash</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Discharge Fever</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Discharge Nosebleed</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
              <event>
                <sub_title>Discharge Wind Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="276"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="276"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>13% of patients were judged to have nonevaluable cCTA images on the basis of a pre-defined image quality score. This number may be reduced with improvement of CT acquisition techniques as well a refinement of the FFRct technology.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>VP Clinical, Quality &amp; Regulatory Affairs</name_or_title>
      <organization>HeartFlow</organization>
      <phone>650-241-1221</phone>
      <email>clinicalresearch@heartflow.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

